Patent Litigation Involving Cancer Immunotherapy
This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Background
A biopharmaceutical company had exclusively licensed a patent related to CAR-T therapy, a novel type of cancer immunotherapy that modifies a patient’s T cells to target and kill cancer more effectively. Its primary competitor had previously attempted to license and invalidate the patent, but failed at both. Despite being aware of potential infringement claims against its therapy, the competitor prioritized being first to market for its lead indication, attempting to lock in a sizeable portion of what was viewed to be a blockbuster marketplace. Upon its competitor achieving FDA approval, the company filed patent infringement claims against its competitor and its therapy.
Our Analysis
Intensity was called upon to evaluate the damages related to the alleged infringement. For this project, Intensity conducted economic analysis and provided trial testimony to determine reasonable royalties. This included an assessment of the economic contribution of the patented technology to the allegedly infringing product, availability of potential non-infringing alternatives, stage of development of licensed technology, competitive relationship between the two parties, financial harms and benefits from use of the patented technology by the alleged infringer, and market analysis of related license agreements. As part of its work, Intensity evaluated all fifteen of the Georgia-Pacific factors.
Intensity submitted an expert report and provided expert testimony at deposition and trial. After an eight-day trial, the jury returned a verdict in favor of Intensity’s client with a damages award that precisely matched the trial testimony.
Economic issues included: Apportionment; Discounted Cash Flow; Licensing; Reasonable Royalty; Valuation.
Latest Insights
Article | August 19, 2025
Overtaken by Events: What Delay Quantification Can Tell Us About Causality
In the International Construction Law Review, Stuart Jones presents an innovative approach to delay analysis in construction disputes. His article, “Overtaken by Events: What Delay Quantification Can Tell Us About Causality,” introduces a forensic and mathematical framework that challenges conventional assumptions about project delay and causation.
Article | August 11, 2025
Five Key Recommendations to Strengthen Cybersecurity in Latin America and the Caribbean
Cybersecurity is now a core element of legal, regulatory, and business risk management. In Latin America and the Caribbean, organizations face mounting pressure to demonstrate proactive compliance with evolving data protection laws, cybersecurity mandates, and cross-border disclosure requirements. Boards and legal departments are expected not only to prevent cyber incidents but also to prove due diligence, resilience planning, and rapid response capabilities when they occur.
See All Insights
Talk to Our Insightful Experts